SCHEMBL7689853

SCHEMBL7689853

CCCCC(NC(=O)c1ccccc1C=Cc1ccc(OC)c(OC)c1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 7/20 0.59
CTSB P07858 5/20 0.51
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 3/20 0.48
POLB P06746 2/20 0.48
PKM P14618 2/20 0.48
CTSL P07711 2/20 0.42
CNR2 P34972 1/20 0.41
TAS1R3 Q7RTX0 2/20 0.41
TAS1R1 Q7RTX1 2/20 0.41
CTSS P25774 2/20 0.41
CTSK P43235 2/20 0.41
CYP1A2 P05177 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP1B1 Q16678 1/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697828 1.00 CAPN1 (0.59) CAPN1CTSBALDH1A1KDM4EPOLB
SCHEMBL7692806 0.95 CAPN1 (0.60) CAPN1CTSBALDH1A1KDM4EPOLB
SCHEMBL7690894 0.91 CAPN1 (0.58) CAPN1CTSBALDH1A1KDM4EPOLB
SCHEMBL7696610 0.91 CAPN1 (0.58) CAPN1CTSBALDH1A1KDM4EPOLB
SCHEMBL7694185 0.87 CAPN1 (0.56) CAPN1CTSBALDH1A1KDM4ECTSL
SCHEMBL7697322 0.87 CAPN1 (0.54) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7690746 0.86 CAPN1 (0.56) CAPN1CTSBALDH1A1KDM4EPKM
SCHEMBL7693912 0.82 CAPN1 (0.73) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7690836 0.82 CAPN1 (0.48) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7696672 0.81 CAPN1 (0.56) CAPN1CTSBCTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed